G protein-coupled receptors (GPCRs) remain one of the most valuable and versatile classes of drug targets in modern medicine. This blog explores the evolving landscape of GPCR drug discovery, highlighting recent advances in therapeutic development, receptor targeting, and disease indications. From classical roles in cardiovascular and neurological disorders to emerging applications in cancer, autoimmune conditions, […]
Author Archives: truemeds
Latest Progress in AI Drug Development. Drug development is an inherently complex and protracted endeavor, traditionally guided by expert intuition and iterative trial-and-error experimentation. The integration of AI-driven methodologies into various stages of the drug development pipeline is already yielding subtle yet significant gains in both efficiency and effectiveness. This article offers a comprehensive overview […]
ε-Poly-L-lysine (ε-PL) is a widely used natural antimicrobial agent, but its commercial production is often limited by low fermentation yields due to high intracellular ATP demand. A recent study introduced a novel metabolic engineering approach by integrating a polyphosphate kinase (PPK)-mediated ATP regeneration system into Streptomyces albulus. By coexpressing polyP:AMP phosphotransferase (PAP) and PPK2Bcg, the […]
Targeted Protein Degradation (TPD) is revolutionizing cancer treatment by offering a novel mechanism to eliminate disease-driving proteins rather than merely inhibiting them. At the forefront of this innovation are PROTACs (Proteolysis-Targeting Chimeras), which harness the cell’s own degradation machinery to selectively remove oncogenic proteins. This blog explores the fundamental principles behind PROTACs, highlights their clinical […]
Small molecule chemical probes are essential tools in modern biomedical research, offering targeted, reversible modulation of specific proteins or pathways. This blog post explores what chemical probes are, how they work, their defining features, and their applications across cancer, neuroscience, immunology, and beyond. It also introduces best practices for selecting and using probes, showcases notable […]
Procyanidin C1 (PCC1) is a trimeric polyphenol derived from sources like grape seed, cocoa, and apples, now gaining recognition for its broad-spectrum health benefits. This blog explores the compound’s antioxidant, anti-inflammatory, neuroprotective, and senolytic properties, highlighting its role in anti-aging, cardiovascular support, and skincare. From promoting cellular health to showing promise in cancer research and […]
Growth factors (GFs) are essential regulators of cell proliferation, acting through receptor tyrosine kinases (RTKs) to activate intracellular signaling pathways that control progression through the cell cycle. While their influence on G1 phase entry is well-established, recent studies have uncovered broader roles for growth factor-induced signaling, including impacts on DNA replication, checkpoint control, and mitosis. […]
Amino acids are no longer viewed merely as protein building blocks—they are now recognized as powerful regulators of human health and disease. Recent research has uncovered their vital roles in cancer proliferation, metabolic disorders like diabetes and obesity, immune cell activation, and neurological development. This blog explores how tumors hijack amino acid metabolism for growth, […]
Inavolisib is a promising PI3K-alpha selective inhibitor under investigation for its potential in treating cancers that depend on the PI3K pathway. By targeting the PI3K-alpha isoform, Inavolisib disrupts the signaling cascade that promotes tumor cell growth and survival. This targeted approach aims to reduce the side effects associated with broader PI3K inhibition. Clinical trials have […]
MTX-531 is a novel dual inhibitor targeting the EGFR and PI3K pathways, frequently activated in various cancers, driving proliferation, survival, and drug resistance. Developed by researchers at the University of Michigan, MTX-531 exhibits significant antitumor efficacy in preclinical models, particularly head and neck squamous cell carcinoma (HNSCC) and colorectal cancer (CRC) harboring KRAS-G12C and PIK3CA […]